Ellie is a UK and European qualified patent attorney with a strong academic background in Life Sciences, particularly in Plant Sciences. In addition, Ellie holds a qualification as a Patent Attorney Litigator with advocacy experience working on oppositions and appeals before the European Patent Office. She specialises in dealing with technology in the Gene Editing, Antibody, Peptide, AgBio, and Microbiology fields. Ellie is interested in helping SMEs, start-ups and spin-outs maximise their potential by exploiting IP protection and good IP management. She enjoys working with challenging IP portfolios and developing IP strategies. In particular for those cases experiencing difficulty in European prosecution.
Ellie has worked with all types of clients, from multinational companies including AstraZeneca, Novartis, and Dow AgroSciences, to small start ups and spin outs such as Pepgen and Tissue Regenix.
(Cantab) Natural Sciences - Double First Class Honours
Intellectual Property Litigation and Advocacy Certificate - Nottingham Trent University - Distinction
Awarded to undergraduates who achieved a first class in university examinations, achieved in 2009 and 2010
Awarded to undergraduate who achieved highest overall marks in Plant Sciences, awarded in 2009 and 2010
Awarded by CIPA to the patent trainee who achieved the highest mark in the P7 examination (UK trademark law)
September 22nd 2022
July 2nd 2021
January 7th 2021
November 4th 2020
Ellie regularly holds tutorials for trainees within HGF, and has acted as an ongoing mentor for those trainees taking UK finals examinations.
She has also recently acted as a CIPA designated mentor for candidates re-taking the UK law exam (FD1).
In the past, Ellie held the position of the Northern Informals Secretary for several years organising social and educational events for trainees across the North of England, including organising and implementing a series of tutorials with tutors from different firms.
Case study – alt fat innovation Many companies and investors are aware of the importance of identifying and protecting their innovations, and in particular of the importance of obtaining patents …Read article
HGF will be exhibiting at The North East Automotive Alliance’s flagship Expo on 29th September 2022. The event is an industry highlight for companies operating within the region’s automotive supply …Event details
Medical Technology Ireland Conference 2022 will be held on 21-22 September at the Galway Racecource. Medical Technology Ireland is a new high-profile National and International event attracting global suppliers to …Event details
Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …Read article
Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder . …Read article
Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …Read article
Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …Read article
Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …Read article
If you would like to discuss how HGF could help you, contact one of our IP specialists.